|
Nautilus Biotechnology Inc (NASDAQ: NAUT) |
|
Nautilus Biotechnology Inc
NAUT's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Nautilus Biotechnology Inc 's sales fell
in IV. Quarter 2024 from the same quarter a year ago.
Laboratory Analytical Instruments industry recorded
growth of revenues by 3.29 %
Nautilus Biotechnology Inc net loss increased from $-17 millions, to $-18 millions in IV. Quarter 2024,
• More on NAUT's Growth
|
|
Nautilus Biotechnology Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 11.8 in trailing twelve-month period. Laboratory Analytical Instruments industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
9.26 |
PE TTM
|
|
Laboratory Analytical Instruments industry's Price to Sales ratio is at 3.81.
• More on NAUT's Valuation
|
|
|
|
|
Nautilus Biotechnology Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 11.8 in trailing twelve-month period. Laboratory Analytical Instruments industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
9.26 |
PE TTM
|
|
Laboratory Analytical Instruments industry's Price to Sales ratio is at 3.81.
Nautilus Biotechnology Inc Price to Book Ratio is at 0.47 lower than Industry Avg. of 205.09. and higher than S&P 500 Avg. of 0.01
• More on NAUT's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com